Upgrading facilities to study infectious diseases and develop treatments
Official title: Modernization of high and maximum containment research facilities at the National Emerging Infectious Diseases Laboratories (NEIDL) to meet current and future national research priorities
Funded at Boston University Medical Campus · NIH-11015517 · Data updated 2026-11-12
This study is working to upgrade the labs at Boston University that study dangerous germs, like COVID-19, so that scientists can create better vaccines and treatments to help keep everyone safe during outbreaks and future pandemics.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University Medical Campus NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | September 17, 2024 |
| Project end | May 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $7,541,758 |
| NIH project number | 1C06OD037773-01 |
| Project ID | NIH-11015517 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals affected by or at risk for infectious diseases, particularly those related to emerging pathogens like SARS-CoV-2.
✕Less likely to help
Patients with chronic conditions unrelated to infectious diseases may not receive direct benefits from this research.
What this research studies
This research focuses on modernizing the National Emerging Infectious Diseases Laboratories (NEIDL) at Boston University to enhance the study of new and reemerging infectious pathogens, including the COVID-19 virus. By improving the infrastructure and operational efficiency of high and maximum containment labs, the project aims to facilitate the development of vaccines, therapeutics, and diagnostics. Patients can benefit from this research as it aims to address urgent public health needs and improve responses to future pandemics. The approach includes upgrading containment measures and enhancing research capabilities to allow for more effective studies on various pathogens.
Why it matters
Potential benefit: If successful, this research could lead to faster development of effective vaccines and treatments for infectious diseases, ultimately improving patient outcomes during pandemics.
How similar studies have gone: Other research initiatives focused on upgrading containment facilities have shown success in enhancing the study of infectious diseases, indicating that this approach is both tested and necessary.
Where this research is happening
-
Boston University Medical Campus
Boston, United States Active
Researchers
- Principal investigator: Sullivan, Nancy Jean — Boston University Medical Campus
- Study coordinator: Sullivan, Nancy Jean
Related research
Other NIH-funded projects on the same topics.
-
Creating a detailed map of early lung cancer changes
This study is looking at early changes in lung tissue that can lead to cancer, specifically focusing on common types of lung cancer, and it's for patients who want to help researchers understand these changes better so they can improve early detection and treatment.
-
Telomere trouble in ALT cancers: what causes damage and how it happens
Researchers are studying why some cancer cells use ALT to lengthen telomeres and how replication stress damages telomeres, aiming to uncover key processes that could be targeted in patients.
-
IL-6 signaling, lung injury, and post-TB lung disease in TB/HIV
This grant tests how a specific immune signal (IL-6) relates to lung damage after tuberculosis in people with and without HIV, aiming to understand who is at risk for lasting lung problems.
-
IL-6 signaling and lung injury after TB and HIV co-infection
This project looks at how a common immune signal called IL-6 relates to lung injury after TB treatment, especially in people who also have HIV.
-
LEAD Africa: advancing Alzheimer’s research across Africa
A new project aims to build Alzheimer’s disease research capabilities in Africa to improve understanding and care for people with dementia.
-
Leading AD and related dementias research in Africa
A multi-country effort aims to build Africa’s capacity to study Alzheimer’s disease and related dementias using scalable, low-cost methods.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.